Boston Scientific BSX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $850M+146% | $965M+165% | $893M+11.2% | $388M-51.1% | $345M-10.2% | ||
| $71M-31.1% | —— | $98M+40.0% | $109M+45.3% | $103M+10.8% | ||
| $3.15B+12.4% | $3.06B+14.7% | $2.96B+13.4% | $2.93B+16.8% | $2.81B+16.3% | ||
| $3.12B+8.7% | $2.94B+4.7% | $2.92B+6.1% | $2.86B+9.7% | $2.87B+11.9% | ||
| $928M+10.1% | $849M+3.7% | $849M-1.3% | $835M-1.6% | $843M+3.1% | ||
| $259M+18.8% | $246M+27.5% | $245M+18.9% | $218M+8.5% | $218M+16.0% | ||
| $729M-3.6% | $660M-20.6% | $701M+4.0% | $613M-18.9% | $756M+12.7% | ||
| $358M+21.8% | $299M-2.6% | $310M-6.6% | $298M-5.4% | $294M-7.8% | ||
| $219M+1,891% | $181M+129% | —— | —— | $11M-91.2% | ||
| $8.68B+18.4% | $8.79B+27.1% | $8.04B-8.3% | $7.12B-20.8% | $7.34B-10.4% | ||
| $4.06B+19.9% | $4.04B+22.5% | $3.8B+23.5% | $3.46B+17.3% | $3.39B+17.0% | ||
| $188M+29.7% | $173M+20.1% | $147M+2.8% | $147M+5.0% | $145M+2.8% | ||
| $2.52B+20.1% | $2.48B+23.0% | $2.54B+32.6% | $2.15B+14.7% | $2.1B+12.9% | ||
| $3.67B+0.9% | $3.61B+2.2% | $3.86B+6.6% | $3.78B+6.2% | $3.64B+3.2% | ||
| $18.54B+6.9% | $18.28B+7.0% | $18.21B+21.2% | $18.08B+25.6% | $17.34B+20.7% | ||
| $16M— | $17M— | —— | —— | —— | ||
| $44.35B+10.5% | $43.67B+10.9% | $42.71B+12.2% | $41.56B+12.0% | $40.14B+9.5% | ||
| $1.14B+13.6% | $1.14B+19.2% | $1B+10.5% | $962M+6.2% | $1B+9.0% | ||
| —— | $1M— | —— | —— | —— | ||
| $4.57B-9.6% | $5.44B-15.0% | $5.33B-9.8% | $5.19B-6.9% | $5.06B+2.9% | ||
| $2.47B+26.9% | $2.41B+28.6% | $2.39B+29.8% | $2.38B+32.4% | $1.95B+1.4% | ||
| $1.58B— | $1.7B— | —— | —— | —— | ||
| $6.91B+107% | $5.57B+108% | $4.9B+133% | $4.14B+153% | $3.35B+155% | ||
| -$398M-1,321% | -$610M-322% | -$689M-438% | -$722M-540% | -$28M-121% | ||
| $25.86B+16.4% | $24.23B+11.3% | $23.39B+13.0% | $22.42B+10.0% | $22.21B+11.5% | ||
| $44.35B+10.5% | $43.67B+10.9% | $42.71B+12.2% | $41.56B+12.0% | $40.14B+9.5% | ||
| $127M+12.4% | $132M+21.1% | $133M+22.0% | $112M+6.7% | $113M+3.7% | ||
| $1.93B+7.0% | $1.85B+2.8% | $1.83B+8.3% | $1.81B+16.0% | $1.81B+16.1% | ||
| $219M-5.6% | $181M-52.9% | $125M-33.5% | $91M-70.9% | $232M-23.2% | ||
| $396M+33.3% | $286M+3.2% | $310M+12.3% | $292M+20.2% | $297M+36.2% | ||
| $9.9B0.0% | $9.9B0.0% | $9.9B— | $9.9B— | $9.9B— | ||
| $2.05B+12.0% | $1.87B+6.4% | $1.83B+11.6% | $1.86B+20.2% | $1.83B+14.9% | ||
| $334M-10.7% | —— | $375M+47.1% | $321M+37.8% | $374M+57.8% | ||
| $396M+33.3% | $286M+3.2% | $310M+12.3% | $292M+20.2% | $297M+36.2% | ||
| $770M+719% | $813M+765% | $813M+765% | $813M+280% | $94M-46.0% | ||
| $770M+719% | $813M+765% | $813M+765% | $813M+280% | $94M-46.0% | ||
| $770M+719% | $813M+765% | $813M+765% | $813M+280% | $94M-46.0% | ||
| $770M+719% | $813M+765% | $813M+765% | $813M+280% | $94M-46.0% | ||
| $396M+33.3% | $286M+3.2% | $310M+12.3% | $292M+20.2% | $297M+36.2% | ||
| $547M+22.1% | $465M+3.6% | $495M+16.2% | $492M+18.3% | $448M+4.2% | ||
| $3.95B+7.5% | $3.68B+0.5% | $3.67B-3.9% | $3.78B-0.6% | $3.68B-3.1% | ||
| $7.06B+7.5% | $7.02B+5.0% | $7.16B+24.5% | $7.26B+34.0% | $6.57B+12.5% | ||
| $705M+7.6% | $681M+22.7% | $643M+20.9% | $626M+39.1% | $655M+52.7% | ||
| $547M+22.1% | $465M+3.6% | $495M+16.2% | $492M+18.3% | $448M+4.2% | ||
| $44.35B+10.5% | $43.67B+10.9% | $42.71B— | $41.56B— | $40.14B— | ||
| $2.05B+12.0% | $1.87B+6.4% | $1.83B+11.6% | $1.86B+20.2% | $1.83B+14.9% | ||
| $4.06B— | $4.04B+22.5% | $3.8B— | —— | —— | ||
| $7.74B+10.0% | $7.65B+12.0% | $7.66B+14.4% | $7.24B+11.2% | $7.03B+9.4% | ||
| $547M+22.1% | $465M+3.6% | $495M+16.2% | $492M+18.3% | $448M+4.2% | ||
| $2.05B+12.0% | $1.87B+6.4% | $1.83B+11.6% | $1.86B+20.2% | $1.83B+14.9% | ||
| $2.51B+6.8% | $3.2B+15.4% | $2.98B+21.2% | $2.8B+20.6% | $2.35B+13.0% | ||
| $2.51B+6.8% | $3.2B+15.4% | $2.98B+21.2% | $2.8B+20.6% | $2.35B+13.0% | ||
| $875M-5.2% | $795M-10.4% | $862M-3.3% | $952M+23.6% | $923M+11.6% | ||
| $1.23B+17.5% | $1.31B+32.1% | $1.33B+22.1% | $1.42B+45.4% | $1.05B+6.2% | ||
| $145M+12.4% | $144M+2.9% | $151M+10.2% | $139M+6.1% | $129M-7.9% | ||
| $10.99B+4.3% | $11.14B+24.2% | $11.12B+20.4% | $11.11B+23.5% | $10.53B+10.5% | ||
| $21.58B+2.2% | $21.51B+2.1% | $21.42B+2.2% | $21.23B+2.1% | $21.13B+2.0% | ||
| $17M0.0% | $17M0.0% | $17M0.0% | $17M0.0% | $17M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $2.25B0.0% | $2.25B0.0% | $2.25B0.0% | $2.25B0.0% | $2.25B0.0% | ||
| $14.63B+38.8% | $13.72B+58.8% | $13.08B+75.0% | $11.83B+71.5% | $10.54B+51.6% | ||
| $1.23B+17.5% | $1.31B+32.1% | $1.33B+22.1% | $1.42B+45.4% | $1.05B+6.2% | ||
| $127M+12.4% | $132M+21.1% | $133M+22.0% | $112M+6.7% | $113M+3.7% | ||
| $354M+65.4% | $385M+125% | $378M+121% | $367M+25.3% | $214M-21.6% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 2B0.0% | 2B0.0% | 2B0.0% | 2B0.0% | 2B0.0% | ||
| —— | 1.7B+0.5% | 1.7B— | 1.7B+0.5% | 1.7B— | ||
| $1.12B+10.5% | $1.16B+12.2% | $936M-3.1% | $1.04B+16.1% | $1.01B+14.7% | ||
| $686M+7.0% | $682M+7.4% | $668M+8.1% | $662M+10.5% | $641M+8.1% | ||
| $41M-94.7% | $299M-83.2% | $483M-70.8% | $480M-69.6% | $777M-28.4% | ||
| $10.59B-2.9% | $11.15B+8.0% | $11.16B+4.0% | $11.32B+12.3% | $10.9B+6.6% | ||
| $219M+38.6% | $220M+41.9% | $242M+75.4% | $226M+71.2% | $158M+19.7% | ||
| $219M-5.6% | $181M-52.9% | $125M-33.5% | $91M-70.9% | $232M-23.2% | ||
| $1.23B+17.5% | $1.31B+32.1% | $1.33B+22.1% | $1.42B+45.4% | $1.05B+6.2% | ||
| $1.23B— | $1.31B— | —— | —— | —— | ||
| $14.63B+38.8% | $13.72B+58.8% | $13.08B+75.0% | $11.83B+71.5% | $10.54B+51.6% | ||
| $3.92B+3.6% | $3.83B+5.4% | $4.04B+9.9% | $3.9B+8.5% | $3.78B+6.5% | ||
| $334M-10.7% | —— | $375M+47.1% | $321M+37.8% | $374M+57.8% | ||
| $309M-13.7% | $396M+42.4% | $334M+30.5% | $334M+61.4% | $358M+69.7% | ||
| $396M+33.3% | $286M+3.2% | $310M+12.3% | $292M+20.2% | $297M+36.2% | ||
| —— | $1M— | —— | —— | —— | ||
| $11.7B+8.1% | $11.46B+8.1% | $11.23B+6.7% | $11B+6.7% | $10.82B+6.1% | ||
| $17.99B+4.0% | $17.67B+2.8% | $17.58B+8.6% | $17.45B+12.5% | $17.29B+9.0% | ||
| $28.44B+4.4% | $28.18B+4.4% | $28.11B— | $27.98B— | $27.24B— | ||
| $9.9B0.0% | $9.9B0.0% | $9.9B— | $9.9B— | $9.9B— | ||
| $770M+719% | $813M+765% | $813M+765% | $813M+280% | $94M-46.0% | ||
| $1.14B-20.0% | —— | $1.41B-2.5% | $1.41B-2.3% | $1.43B-1.9% | ||
| $193M-11.5% | $203M-1.5% | $223M+3.2% | $220M+16.4% | $218M+25.3% | ||
| $0— | $7M— | —— | —— | —— | ||
| $1.16B+16.0% | —— | $1B0.0% | $1B0.0% | $1B0.0% | ||
| $10.99B+4.3% | $11.14B+24.2% | $11.12B+20.4% | $11.11B+23.5% | $10.53B+10.5% | ||
| $229M-27.5% | $242M-25.8% | $306M+22.4% | $300M+19.5% | $316M+11.7% | ||
| $240M+3.0% | $239M+2.6% | $236M-4.8% | $235M-1.3% | $233M-3.7% | ||
| $684M— | $1.08B— | —— | —— | —— | ||
| $30.21B+8.9% | $29.8B+8.3% | $29.67B— | $29.29B— | $27.74B— | ||
| —— | —— | —— | —— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 50M0.0% | 50M0.0% | 50M0.0% | 50M0.0% | 50M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $119M+30.8% | —— | $103M+32.1% | $98M+32.4% | $91M+23.0% | ||
| $4B— | —— | —— | —— | —— | ||
| 263.3M0.0% | 263.3M0.0% | 263.3M0.0% | 263.3M0.0% | 263.3M0.0% | ||
| $132M-12.6% | —— | $115M-17.3% | $106M-35.0% | $151M-7.9% | ||
| $609M+18.5% | $596M+17.8% | $529M+7.3% | $531M+11.1% | $514M+10.5% | ||
| $512M+18.8% | $501M+18.4% | $444M+6.5% | $447M+10.1% | $431M+9.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's total assets?
- Boston Scientific (BSX) holds $44.4B in total assets, up 10.5% year over year.
- How much cash does Boston Scientific have?
- Boston Scientific holds $850.0M in cash and equivalents.
- Can Boston Scientific cover its short-term obligations?
- Its current ratio is 1.90 — current assets exceed current liabilities.
- Where does Boston Scientific's balance sheet data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
